Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Tarlatamab treatment · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Tarlatamab | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Tarlatamab treatment | DRUG | Tarlatamab will be administered as an IV infusion |
Inclusion Criteria: 1. An Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0, 1 or 2. 2. A confirmed diagnosis of neuro-endocrine carcinoma of the gynecological tract including small cell cervical cancer or other high-grade neuro-endocrine carcinoma from the vulva or vagina. Mixed...